HAVCR2 and cancer: Our data suggest that tissue inhibitors of metalloproteases (TIMPs) might counteract cancer-induced NK polarization, by restoring the expression of activation markers like NKG2D and reducing the expression of exhaustion markers such as CD9, CD49a, and the T-cell immunoglobulin and mucin-domain containing-3 (TIM-3) (75).